XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.
T
T

Teleflex


Berita

U.S. STOCKS Spirit Airlines, Labcorp, Air Products and Chemicals

BUZZ-U.S. STOCKS ON THE MOVE-Spirit Airlines, Labcorp, Air Products and Chemicals Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes fell over 1% on Thursday, bogged down by megacap tech and chip stocks, while small-caps bore the brunt of selling pressure as weak manufacturing data renewed concerns around a slowdown in the U.S.
B
I
J
Q
W
C
U
U
A
B
F
L
T

Teleflex rises after lifting 2024 profit forecast

BUZZ-Teleflex rises after lifting 2024 profit forecast ** Shares of Teleflex TFX.N rise as much as 10.4% to an over five-month high of $243.88 ** Medical device maker raises its annual adj EPS forecast to $13.80 to $14.20 from its previous outlook of $13.60 to $13.95 ** Co's Q2 adj EPS of $3.42 tops analysts' estimates of $3.33 - LSEG ** TFX also s
T

Teleflex Inc reports results for the quarter ended in January - Earnings Summary

Teleflex Inc reports results for the quarter ended in January - Earnings Summary Teleflex Inc TFX.N reported quarterly adjusted earnings of $3.42​​ per share for the quarter ended in January, higher than the same quarter last year, when the company reported EPS of $3.41. The mean expectation of fifteen analysts for the quarter was for earnings of $3.33 per share.
T

Teleflex raises 2024 profit forecast on medical device demand

Teleflex raises 2024 profit forecast on medical device demand Aug 1 (Reuters) - Surgical equipment maker Teleflex TFX.N raised its annual profit forecast on Thursday, banking on resilient demand for certain surgical procedures at hospitals to drive sales for its medical devices. The company also said its board authorized a share repurchase program for up to $500 million of common stock.
S
T

Teleflex Q2 Adjusted EPS Continuing Operations USD 3.42

BRIEF-Teleflex Q2 Adjusted EPS Continuing Operations USD 3.42 Aug 01 (Reuters) - Teleflex Q2 EPS continuing operations USD 1.69. Q2 revenue USD 749.7 million vs. IBES estimate USD 764.6 million outlook FY EPS continuing operations USD 6.43-6.83 outlook FY adjusted EPS continuing operations USD 13.8-14.2 outlook FY revenue growth 3.4-4.4%
T

Teleflex Inc <TFX.N> expected to post earnings of $3.33 a share - Earnings Preview

Teleflex Inc expected to post earnings of $3.33 a share - Earnings Preview Teleflex Inc TFX.N , TFX is expected to show a rise in quarterly revenue when it reports results on August 1 for the period ending June 30 2024 The Wayne Pennsylvania-based company is expected to report a 2.9% increase in revenue to $764.562 million from $743.26 million a year ago, according to the mean estimate from 13 analysts, based on LSEG data.The company's guidance on May 14 2024, for the period ended June 30, was f
T

Teleflex Awarded Hemostasis Products Agreements With Premier

BRIEF-Teleflex Awarded Hemostasis Products Agreements With Premier July 29 (Reuters) - Teleflex Inc TFX.N : TELEFLEX AWARDED HEMOSTASIS PRODUCTS AGREEMENTS WITH PREMIER, INC. TELEFLEX INC - AWARDED TWO GROUP PURCHASING AGREEMENTS WITH PREMIER Source text for Eikon: ID:nGNX1Whs68 Further company coverage: TFX.N
T

U.S. Alphabet, Domino's Pizza, McKesson

U.S. RESEARCH ROUNDUP-Alphabet, Domino's Pizza, McKesson July 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alphabet, Domino's Pizza and McKesson, on Tuesday. HIGHLIGHTS * Alphabet Inc GOOGL.O : Jefferies raises target price to $220 from $215 * Domino's Pizza Inc DPZ.N : Baird raises to outperform; raises target to $580 from $530 * McKesson Corp MCK.N : Baird raises target price to $694 from $679 * Teleflex Inc T
A
A
C
C
G
M
C
A
C
T

U.S. AT&T, ATI, California Resources

U.S. RESEARCH ROUNDUP-AT&T, ATI, California Resources July 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AT&T, ATI and California Resources, on Monday. HIGHLIGHTS * AT&T Inc T.N : JP Morgan adds stock to its U.S. analyst focus list * ATI Inc ATI.N : JP Morgan removes stock from its U.S.
A
I
N
W
H
Z
T
U

US FDA classifies recall of Teleflex's inflatable devices as 'most serious'

US FDA classifies recall of Teleflex's inflatable devices as 'most serious' June 13 (Reuters) - The U.S. Food and Drug Administration classified a recall of Teleflex's TFX.N inflatable devices that increase blood supply to the heart muscle as "most serious". The devices are used in patients undergoing cardiac and non-cardiac surgery, and to treat those who have had heart failure or have acute coronary syndrome, a group of diseases in which blood flow to the heart decreases.
T



Syarat

Aset Popular

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.